NKTR - NEKTAR THERAPEUTICS

70.7
-1.750   -2.475%

Share volume: 734,773
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$72.45
-1.75
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-09-2024 08-08-2024 11-07-2024 03-14-2025 05-08-2025 08-07-2025 11-06-2025
Total revenue 21.639 M 23.489 M 24.124 M 29.175 M 10.460 M 11.175 M 11.790 M
Cost of revenue 8.534 M 9.740 M 4.435 M 7.977 M 0.000 0.000 0.000
Gross profit 13.105 M 13.749 M 19.689 M 21.198 M 10.460 M 11.175 M 11.790 M
    4.91% 43.20% 7.66% -50.66% 6.84% 5.50%  
Operating expenses 47.557 M 50.234 M 53.988 M 45.880 M 54.826 M 46.958 M 43.322 M
Selling general and admin 20.149 M 20.510 M 18.957 M 17.135 M 24.346 M 17.072 M 16.070 M
Research and development 27.408 M 29.724 M 35.031 M 28.745 M 30.480 M 29.886 M 27.252 M
Total expenses 48.532 M 63.523 M 54.034 M 6.850 M 54.995 M 47.405 M 43.462 M
    30.89% -14.94% -87.32% 702.85% -13.80% -8.32%  
Operating income -35.427 M -49.774 M -34.345 M 14.348 M -44.535 M -36.230 M -31.672 M
Ebit -35.526 M -49.810 M -34.465 M 14.213 M -44.269 M -35.970 M -31.793 M
Pretax income -36.837 M -52.317 M -37.048 M 7.002 M -46.369 M -39.395 M -35.021 M
    42.02% -29.19% -118.90% -762.23% -15.04% -11.10%  
Income tax -35.000 K 46.000 K 9.000 K -259.000 K 52.000 K -188.000 K -33.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -36.802 M -52.363 M -37.057 M 7.261 M -50.882 M -41.593 M -35.522 M
    -42.28% 29.23% 119.59% -800.76% 18.26% 14.60%